nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprost Tromethamine—GALR3—uterus—cervical cancer	0.035	0.0468	CbGeAlD
Dinoprost Tromethamine—GALR3—female reproductive system—cervical cancer	0.0315	0.0421	CbGeAlD
Dinoprost Tromethamine—TBXA2R—epithelium—cervical cancer	0.0251	0.0335	CbGeAlD
Dinoprost Tromethamine—TBXA2R—decidua—cervical cancer	0.0237	0.0317	CbGeAlD
Dinoprost Tromethamine—PTGER1—renal system—cervical cancer	0.0204	0.0273	CbGeAlD
Dinoprost Tromethamine—TBXA2R—female reproductive system—cervical cancer	0.0186	0.0249	CbGeAlD
Dinoprost Tromethamine—PTGER3—renal system—cervical cancer	0.0179	0.0239	CbGeAlD
Dinoprost Tromethamine—TBXA2R—vagina—cervical cancer	0.0168	0.0225	CbGeAlD
Dinoprost Tromethamine—HPGDS—epithelium—cervical cancer	0.0167	0.0223	CbGeAlD
Dinoprost Tromethamine—HPGDS—uterine cervix—cervical cancer	0.0165	0.0221	CbGeAlD
Dinoprost Tromethamine—PTGER1—female reproductive system—cervical cancer	0.0163	0.0219	CbGeAlD
Dinoprost Tromethamine—PTGER3—uterus—cervical cancer	0.0159	0.0213	CbGeAlD
Dinoprost Tromethamine—HPGDS—decidua—cervical cancer	0.0157	0.0211	CbGeAlD
Dinoprost Tromethamine—HPGDS—renal system—cervical cancer	0.0155	0.0207	CbGeAlD
Dinoprost Tromethamine—HPGDS—endometrium—cervical cancer	0.0149	0.02	CbGeAlD
Dinoprost Tromethamine—PTGER1—female gonad—cervical cancer	0.0149	0.0199	CbGeAlD
Dinoprost Tromethamine—HPGDS—mammalian vulva—cervical cancer	0.0145	0.0194	CbGeAlD
Dinoprost Tromethamine—PTGER3—female reproductive system—cervical cancer	0.0143	0.0192	CbGeAlD
Dinoprost Tromethamine—HPGDS—uterus—cervical cancer	0.0138	0.0184	CbGeAlD
Dinoprost Tromethamine—PTGIR—epithelium—cervical cancer	0.0136	0.0182	CbGeAlD
Dinoprost Tromethamine—PTGER3—female gonad—cervical cancer	0.013	0.0174	CbGeAlD
Dinoprost Tromethamine—PTGFR—uterus—cervical cancer	0.0127	0.0171	CbGeAlD
Dinoprost Tromethamine—PTGIR—renal system—cervical cancer	0.0126	0.0169	CbGeAlD
Dinoprost Tromethamine—HPGDS—female reproductive system—cervical cancer	0.0124	0.0166	CbGeAlD
Dinoprost Tromethamine—SLC22A11—renal system—cervical cancer	0.0123	0.0164	CbGeAlD
Dinoprost Tromethamine—SLC22A7—renal system—cervical cancer	0.012	0.016	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—uterine cervix—cervical cancer	0.0119	0.0159	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—epithelium—cervical cancer	0.0119	0.0159	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—uterine cervix—cervical cancer	0.0118	0.0158	CbGeAlD
Dinoprost Tromethamine—PTGFR—female reproductive system—cervical cancer	0.0115	0.0153	CbGeAlD
Dinoprost Tromethamine—HPGDS—female gonad—cervical cancer	0.0113	0.0151	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—decidua—cervical cancer	0.0112	0.015	CbGeAlD
Dinoprost Tromethamine—HPGDS—vagina—cervical cancer	0.0112	0.015	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—renal system—cervical cancer	0.0111	0.0149	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—renal system—cervical cancer	0.011	0.0147	CbGeAlD
Dinoprost Tromethamine—TBXA2R—lymph node—cervical cancer	0.0109	0.0146	CbGeAlD
Dinoprost Tromethamine—SLC22A2—renal system—cervical cancer	0.0107	0.0143	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—endometrium—cervical cancer	0.0107	0.0143	CbGeAlD
Dinoprost Tromethamine—PTGFR—female gonad—cervical cancer	0.0104	0.0139	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—mammalian vulva—cervical cancer	0.0104	0.0139	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—mammalian vulva—cervical cancer	0.0103	0.0138	CbGeAlD
Dinoprost Tromethamine—PTGIR—female reproductive system—cervical cancer	0.0101	0.0135	CbGeAlD
Dinoprost Tromethamine—SLC22A11—female reproductive system—cervical cancer	0.00984	0.0132	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—uterus—cervical cancer	0.00981	0.0131	CbGeAlD
Dinoprost Tromethamine—PTGIR—female gonad—cervical cancer	0.00918	0.0123	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—female reproductive system—cervical cancer	0.00891	0.0119	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—female reproductive system—cervical cancer	0.00882	0.0118	CbGeAlD
Dinoprost Tromethamine—PTGER3—lymph node—cervical cancer	0.00838	0.0112	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—female gonad—cervical cancer	0.00811	0.0109	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—vagina—cervical cancer	0.00806	0.0108	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—female gonad—cervical cancer	0.00803	0.0107	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—vagina—cervical cancer	0.00798	0.0107	CbGeAlD
Dinoprost Tromethamine—TBXA2R—G alpha (12/13) signalling events—AKAP13—cervical cancer	0.00734	0.0421	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—lymph node—cervical cancer	0.00724	0.0097	CbGeAlD
Dinoprost Tromethamine—SLC22A8—renal system—cervical cancer	0.00693	0.00927	CbGeAlD
Dinoprost Tromethamine—TBXA2R—Platelet activation, signaling and aggregation—GP6—cervical cancer	0.00681	0.0391	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—lymph node—cervical cancer	0.0067	0.00897	CbGeAlD
Dinoprost Tromethamine—Extravasation—Topotecan—cervical cancer	0.00598	0.0761	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Platelet activation, signaling and aggregation—GP5—cervical cancer	0.00595	0.0342	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—lymph node—cervical cancer	0.0059	0.0079	CbGeAlD
Dinoprost Tromethamine—Respiratory failure—Topotecan—cervical cancer	0.00531	0.0676	CcSEcCtD
Dinoprost Tromethamine—Pulmonary embolism—Topotecan—cervical cancer	0.00522	0.0664	CcSEcCtD
Dinoprost Tromethamine—SLCO3A1—lymph node—cervical cancer	0.00521	0.00698	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—lymph node—cervical cancer	0.00516	0.00691	CbGeAlD
Dinoprost Tromethamine—PTGIR—G alpha (s) signalling events—TAAR6—cervical cancer	0.00473	0.0271	CbGpPWpGaD
Dinoprost Tromethamine—Sepsis—Topotecan—cervical cancer	0.00453	0.0576	CcSEcCtD
Dinoprost Tromethamine—GALR3—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00441	0.0253	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.00432	0.0248	CbGpPWpGaD
Dinoprost Tromethamine—Cardiac arrest—Topotecan—cervical cancer	0.0036	0.0458	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Hemostasis—SERPIND1—cervical cancer	0.00351	0.0201	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—GP6—cervical cancer	0.00351	0.0201	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.00349	0.02	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00342	0.0196	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR ligand binding—TAAR6—cervical cancer	0.00335	0.0192	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00308	0.0177	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—GP5—cervical cancer	0.00307	0.0176	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.00302	0.0173	CbGpPWpGaD
Dinoprost Tromethamine—Sweating—Topotecan—cervical cancer	0.0028	0.0356	CcSEcCtD
Dinoprost Tromethamine—Epistaxis—Topotecan—cervical cancer	0.00275	0.035	CcSEcCtD
Dinoprost Tromethamine—GALR3—GPCR ligand binding—WNT2—cervical cancer	0.00262	0.015	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR ligand binding—TAAR6—cervical cancer	0.0026	0.0149	CbGpPWpGaD
Dinoprost Tromethamine—Angiopathy—Topotecan—cervical cancer	0.00238	0.0302	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Topotecan—cervical cancer	0.00237	0.0301	CcSEcCtD
Dinoprost Tromethamine—Chills—Topotecan—cervical cancer	0.00235	0.0299	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	0.00235	0.0135	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR ligand binding—TAAR6—cervical cancer	0.00235	0.0135	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—GP6—cervical cancer	0.00232	0.0133	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—SERPIND1—cervical cancer	0.00232	0.0133	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.0023	0.0132	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00226	0.0129	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00226	0.0129	CbGpPWpGaD
Dinoprost Tromethamine—Back pain—Topotecan—cervical cancer	0.00221	0.0281	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Topotecan—cervical cancer	0.00219	0.0279	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Topotecan—cervical cancer	0.00212	0.0269	CcSEcCtD
Dinoprost Tromethamine—Malaise—Topotecan—cervical cancer	0.00206	0.0262	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—GPCR ligand binding—WNT2—cervical cancer	0.00203	0.0116	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—GP5—cervical cancer	0.00203	0.0116	CbGpPWpGaD
Dinoprost Tromethamine—Cough—Topotecan—cervical cancer	0.00199	0.0253	CcSEcCtD
Dinoprost Tromethamine—GALR3—GPCR ligand binding—WNT5A—cervical cancer	0.00198	0.0114	CbGpPWpGaD
Dinoprost Tromethamine—Chest pain—Topotecan—cervical cancer	0.00194	0.0247	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Topotecan—cervical cancer	0.00192	0.0244	CcSEcCtD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—TAAR6—cervical cancer	0.0019	0.0109	CbGpPWpGaD
Dinoprost Tromethamine—Infection—Topotecan—cervical cancer	0.00185	0.0235	CcSEcCtD
Dinoprost Tromethamine—PTGER3—GPCR ligand binding—WNT2—cervical cancer	0.00183	0.0105	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Thromboxane A2 receptor signaling—EGFR—cervical cancer	0.00183	0.0105	CbGpPWpGaD
Dinoprost Tromethamine—Hyperhidrosis—Topotecan—cervical cancer	0.0018	0.0229	CcSEcCtD
Dinoprost Tromethamine—PTGFR—GPCR ligand binding—TAAR6—cervical cancer	0.00175	0.0101	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—TAAR6—cervical cancer	0.00172	0.00988	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR ligand binding—TAAR6—cervical cancer	0.00172	0.00985	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR ligand binding—TAAR6—cervical cancer	0.00172	0.00985	CbGpPWpGaD
Dinoprost Tromethamine—Paraesthesia—Topotecan—cervical cancer	0.00167	0.0213	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Topotecan—cervical cancer	0.00166	0.0211	CcSEcCtD
Dinoprost Tromethamine—Pain—Topotecan—cervical cancer	0.00159	0.0202	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—GPCR ligand binding—WNT5A—cervical cancer	0.00154	0.00883	CbGpPWpGaD
Dinoprost Tromethamine—Feeling abnormal—Topotecan—cervical cancer	0.00153	0.0195	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Topotecan—cervical cancer	0.00152	0.0194	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Topotecan—cervical cancer	0.00147	0.0187	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Topotecan—cervical cancer	0.00147	0.0187	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—TAAR6—cervical cancer	0.00147	0.00843	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR ligand binding—WNT5A—cervical cancer	0.00139	0.00796	CbGpPWpGaD
Dinoprost Tromethamine—Hypersensitivity—Topotecan—cervical cancer	0.00137	0.0174	CcSEcCtD
Dinoprost Tromethamine—PTGFR—GPCR ligand binding—WNT2—cervical cancer	0.00137	0.00786	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—WNT2—cervical cancer	0.00134	0.00771	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR ligand binding—WNT2—cervical cancer	0.00134	0.00769	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR ligand binding—WNT2—cervical cancer	0.00134	0.00769	CbGpPWpGaD
Dinoprost Tromethamine—Asthenia—Topotecan—cervical cancer	0.00134	0.017	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—TAAR6—cervical cancer	0.00133	0.00766	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—TAAR6—cervical cancer	0.00133	0.00761	CbGpPWpGaD
Dinoprost Tromethamine—Pruritus—Topotecan—cervical cancer	0.00132	0.0168	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.0013	0.00747	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—AKAP13—cervical cancer	0.0013	0.00745	CbGpPWpGaD
Dinoprost Tromethamine—Diarrhoea—Topotecan—cervical cancer	0.00127	0.0162	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Topotecan—cervical cancer	0.00123	0.0157	CcSEcCtD
Dinoprost Tromethamine—PTGIR—Thromboxane A2 receptor signaling—EGFR—cervical cancer	0.00121	0.00693	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—TAAR6—cervical cancer	0.0012	0.00691	CbGpPWpGaD
Dinoprost Tromethamine—Vomiting—Topotecan—cervical cancer	0.00118	0.0151	CcSEcCtD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—AKAP13—cervical cancer	0.00118	0.00677	CbGpPWpGaD
Dinoprost Tromethamine—Rash—Topotecan—cervical cancer	0.00117	0.0149	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Topotecan—cervical cancer	0.00117	0.0149	CcSEcCtD
Dinoprost Tromethamine—Headache—Topotecan—cervical cancer	0.00117	0.0148	CcSEcCtD
Dinoprost Tromethamine—SLC22A7—Fluoropyrimidine Activity—TP53—cervical cancer	0.00115	0.00657	CbGpPWpGaD
Dinoprost Tromethamine—Nausea—Topotecan—cervical cancer	0.00111	0.0141	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—WNT2—cervical cancer	0.00104	0.00598	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR ligand binding—WNT5A—cervical cancer	0.00104	0.00595	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—WNT5A—cervical cancer	0.00102	0.00584	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—TAAR6—cervical cancer	0.00102	0.00583	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR ligand binding—WNT5A—cervical cancer	0.00102	0.00583	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR ligand binding—WNT5A—cervical cancer	0.00102	0.00583	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—AKAP13—cervical cancer	0.00101	0.00578	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—TAAR6—cervical cancer	0.000991	0.00569	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.000985	0.00565	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—TAAR6—cervical cancer	0.00097	0.00557	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—TAAR6—cervical cancer	0.00097	0.00557	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.00095	0.00545	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—WNT2—cervical cancer	0.00094	0.00539	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—AKAP13—cervical cancer	0.000915	0.00525	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—AKAP13—cervical cancer	0.000909	0.00521	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—TAAR6—cervical cancer	0.0009	0.00516	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—TAAR6—cervical cancer	0.000881	0.00506	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—TAAR6—cervical cancer	0.000881	0.00506	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—AKAP13—cervical cancer	0.000825	0.00473	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—WNT2—cervical cancer	0.000794	0.00455	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—WNT5A—cervical cancer	0.00079	0.00453	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—TAAR6—cervical cancer	0.000789	0.00452	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—CA9—cervical cancer	0.000762	0.00437	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.000752	0.00432	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—WNT5A—cervical cancer	0.000712	0.00409	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—TAAR6—cervical cancer	0.000711	0.00408	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—WNT2—cervical cancer	0.000703	0.00403	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—AKAP13—cervical cancer	0.000697	0.004	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—WNT2—cervical cancer	0.000688	0.00395	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—WNT2—cervical cancer	0.000688	0.00395	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—AKAP13—cervical cancer	0.00068	0.0039	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—AKAP13—cervical cancer	0.000665	0.00382	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—AKAP13—cervical cancer	0.000665	0.00382	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	0.000632	0.00362	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000624	0.00358	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—AKAP13—cervical cancer	0.000617	0.00354	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—WNT2—cervical cancer	0.000616	0.00353	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—AKAP13—cervical cancer	0.000604	0.00347	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—AKAP13—cervical cancer	0.000604	0.00347	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—WNT5A—cervical cancer	0.000602	0.00345	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—WNT2—cervical cancer	0.000555	0.00319	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—AKAP13—cervical cancer	0.00054	0.0031	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—WNT5A—cervical cancer	0.000533	0.00306	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—TAAR6—cervical cancer	0.000532	0.00305	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—WNT5A—cervical cancer	0.000521	0.00299	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—WNT5A—cervical cancer	0.000521	0.00299	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—TAAR6—cervical cancer	0.000521	0.00299	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—TAAR6—cervical cancer	0.000521	0.00299	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—AKAP13—cervical cancer	0.000487	0.0028	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—WNT5A—cervical cancer	0.000467	0.00268	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—NOTCH2—cervical cancer	0.000422	0.00242	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000421	0.00241	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—WNT5A—cervical cancer	0.000421	0.00241	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—WNT2—cervical cancer	0.000415	0.00238	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000412	0.00236	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—WNT2—cervical cancer	0.000406	0.00233	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—WNT2—cervical cancer	0.000406	0.00233	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—AKAP13—cervical cancer	0.000365	0.00209	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—AKAP13—cervical cancer	0.000357	0.00205	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—AKAP13—cervical cancer	0.000357	0.00205	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—HES1—cervical cancer	0.000346	0.00199	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—NOTCH2—cervical cancer	0.000327	0.00188	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—WNT5A—cervical cancer	0.000315	0.00181	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—MTHFR—cervical cancer	0.000309	0.00177	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—WNT5A—cervical cancer	0.000308	0.00177	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—WNT5A—cervical cancer	0.000308	0.00177	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—TERT—cervical cancer	0.000303	0.00174	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—NOTCH2—cervical cancer	0.000295	0.00169	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—FGFR3—cervical cancer	0.000278	0.0016	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—HES1—cervical cancer	0.000268	0.00154	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—TP53—cervical cancer	0.000264	0.00152	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—NOTCH1—cervical cancer	0.000261	0.0015	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—HES1—cervical cancer	0.000242	0.00139	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—TERT—cervical cancer	0.000235	0.00135	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—EGFR—cervical cancer	0.000233	0.00134	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—NOTCH2—cervical cancer	0.000221	0.00127	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—NOTCH2—cervical cancer	0.000216	0.00124	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—NOTCH2—cervical cancer	0.000216	0.00124	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—FGFR3—cervical cancer	0.000216	0.00124	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—TERT—cervical cancer	0.000212	0.00122	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—NOTCH1—cervical cancer	0.000203	0.00116	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CA9—cervical cancer	0.000199	0.00114	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—MTOR—cervical cancer	0.000196	0.00112	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—FGFR3—cervical cancer	0.000195	0.00112	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—NOTCH1—cervical cancer	0.000183	0.00105	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—HES1—cervical cancer	0.000181	0.00104	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—EGFR—cervical cancer	0.000181	0.00104	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CASP3—cervical cancer	0.00018	0.00103	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—HES1—cervical cancer	0.000177	0.00102	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—HES1—cervical cancer	0.000177	0.00102	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—TP53—cervical cancer	0.000174	0.001	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CTNNB1—cervical cancer	0.000174	0.000996	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—EGFR—cervical cancer	0.000163	0.000934	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—TERT—cervical cancer	0.000159	0.00091	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—TERT—cervical cancer	0.000155	0.000891	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—TERT—cervical cancer	0.000155	0.000891	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—MTOR—cervical cancer	0.000152	0.000871	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—STAT3—cervical cancer	0.000151	0.000868	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—FGFR3—cervical cancer	0.000146	0.000835	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—FGFR3—cervical cancer	0.000143	0.000818	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—FGFR3—cervical cancer	0.000143	0.000818	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CASP3—cervical cancer	0.00014	0.000801	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—EGFR—cervical cancer	0.000138	0.000789	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—MTOR—cervical cancer	0.000137	0.000786	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—NOTCH1—cervical cancer	0.000137	0.000784	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CTNNB1—cervical cancer	0.000135	0.000772	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—NOTCH1—cervical cancer	0.000134	0.000768	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—NOTCH1—cervical cancer	0.000134	0.000768	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CASP3—cervical cancer	0.000126	0.000723	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—EGFR—cervical cancer	0.000122	0.000699	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CTNNB1—cervical cancer	0.000121	0.000697	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—EGFR—cervical cancer	0.000119	0.000684	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—EGFR—cervical cancer	0.000119	0.000684	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—STAT3—cervical cancer	0.000117	0.000673	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—TP53—cervical cancer	0.000116	0.000663	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—EGFR—cervical cancer	0.000107	0.000612	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—STAT3—cervical cancer	0.000106	0.000607	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—MTOR—cervical cancer	0.000102	0.000588	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—MTOR—cervical cancer	0.0001	0.000575	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—MTOR—cervical cancer	0.0001	0.000575	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—EGFR—cervical cancer	9.62e-05	0.000552	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CASP3—cervical cancer	9.42e-05	0.00054	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CASP3—cervical cancer	9.22e-05	0.000529	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CASP3—cervical cancer	9.22e-05	0.000529	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CTNNB1—cervical cancer	9.08e-05	0.000521	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—TP53—cervical cancer	8.96e-05	0.000514	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CTNNB1—cervical cancer	8.89e-05	0.00051	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CTNNB1—cervical cancer	8.89e-05	0.00051	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—TP53—cervical cancer	8.08e-05	0.000463	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—MTHFR—cervical cancer	8.06e-05	0.000462	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—STAT3—cervical cancer	7.92e-05	0.000454	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—STAT3—cervical cancer	7.75e-05	0.000445	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—STAT3—cervical cancer	7.75e-05	0.000445	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—EGFR—cervical cancer	7.19e-05	0.000413	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—EGFR—cervical cancer	7.04e-05	0.000404	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—EGFR—cervical cancer	7.04e-05	0.000404	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—TP53—cervical cancer	6.04e-05	0.000347	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—TP53—cervical cancer	5.91e-05	0.000339	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—TP53—cervical cancer	5.91e-05	0.000339	CbGpPWpGaD
